This inventor holds 19 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Abbvie Biotherapeutics Inc., Abbott Biotherapeutics Corp., Protein Design Labs, Inc.. Active years: 1994-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mountain View, CA (US) (1994)
- Milpitas, CA (US) (1997 - 1999)
- Menlo Park, CA (US) (2001 - 2019)
Company Filing History:
6 out of 52 
5 out of 13 
4 out of 29 
Years Active: 1994-2019
Areas of Expertise:
Title: Inventor Spotlight: Nicholas F Landolfi
Introduction: Nicholas F Landolfi is a prolific inventor based in Menlo Park, CA, with an impressive total of 19 patents to his name. His groundbreaking work in the field of therapeutic antibodies has revolutionized the treatment of various disease states, including autoimmune disorders and cancer.
Latest Patents: Among his latest patents is the innovative "Therapeutic use of anti-CS1 antibodies." This invention focuses on developing antagonists of CS1 that can effectively bind to and neutralize key biological activities of CS1. The patent also includes a pharmaceutical composition comprising these antibodies or their fragments, providing a novel method for preventing and treating autoimmune disorders and cancer in patients.
Career Highlights: Nicholas F Landolfi has contributed significantly to the field through his work with companies such as AbbVie Biotherapeutics Inc. and Abbott Biotherapeutics Corp. His expertise in biotechnology and pharmaceuticals has led to the development of cutting-edge treatments that have the potential to improve the lives of countless individuals worldwide.
Collaborations: Throughout his career, Nicholas F Landolfi has collaborated with esteemed colleagues such as J Yun Tso and Marna Williams. These partnerships have been instrumental in advancing research and bringing innovative solutions to fruition within the biomedical industry.
Conclusion: In conclusion, Nicholas F Landolfi stands as a visionary inventor whose dedication to advancing healthcare through innovative technologies has made a lasting impact. His patents and collaborations underscore his remarkable contributions to the field, showcasing his commitment to improving patient outcomes and driving progress in the realm of therapeutic antibodies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile